The Cysteinyl Leukotriene E4 Receptor, GPR99, Orchestrates Airway Epithelial Cell Differentiation and Type 2 Pulmonary Inflammation

半胱氨酰白三烯 E4 受体 GPR99 协调气道上皮细胞分化和 2 型肺部炎症

基本信息

批准号：
10199953
负责人：
Lora Bankova
金额：
$ 13.66万
依托单位：
BRIGHAM AND WOMEN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-07-01 至 2022-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10199953
关键词：
Affinity Airway Disease Allergens Allergic Disease Alternaria Aspirin Asthma Automobile Driving Award Basophils Bioinformatics Biological Biology Bronchoconstriction Brush Cell Cell Count Cell Differentiation process Cell physiology Cells Complement Data Development Development Plans Environment Eosinophilia Epithelial Epithelial Cells Event Five-Year Plans Funding Future Gene Expression Profile Generations Genes Genetic Transcription Genomics Goals Goblet Cells Grant Hospitals Human Hypersensitivity Imaging Techniques Immune Immunity Immunology Inflammation Inflammatory Response Inhalation Interleukin-13 Intestines Knowledge Laboratories Lead Leadership Leukotriene E4 Light Liquid substance Lung Lung Inflammation Lymphoid Cell Mediating Mediator of activation protein Mentorship Metaplasia Metaplastic Cell Methods Modeling Molds Molecular Mucins Mucous Membrane Mus Nose Patients Pharmacology Physicians Population Positioning Attribute Process Production Pulmonary Inflammation Reporter Reporting Research Research Personnel Resistance Resources Role Scientist Secure Severities Signal Transduction Source Structure of mucous membrane of nose Surface Systems Biology TSLP gene Techniques Testing Therapeutic Time Tissues Training Translational Research United States National Institutes of Health Up-Regulation Update Virus Woman Work Writing airborne allergen airway epithelium airway inflammation airway obstruction airway remodeling aspirin-exacerbated respiratory disease career career development cell type curriculum development cysteinyl-leukotriene didactic education disorder control eosinophil gut microbiota inhibitor/antagonist mast cell mucosal site novel profiles in patients receptor recruit research and development respiratory response responsible research conduct skills transcription factor transcriptome transcriptome sequencing translational research program

项目摘要

PROJECT SUMMARY/ABSTRACT: This proposal details a five-year plan to provide the candidate, Lora Bankova, MD, with the knowledge and expertise to become an independent investigator in the field of Allergy and Immunology. The studies focus on a previously unrecognized role of the stable cysteinyl leukotriene (cysLT) metabolite LTE4 in the control of proximal events leading to development of type 2 immunity to the outdoor mold aeroallergen, Alternaria. Using a combination of cellular and molecular approaches, the candidate will test the hypothesis that GPR99 drives innate type 2 immunity and airway remodeling through the control of epithelial cell activation for IL-25 generation. As LTE4 is the only stable cysLT metabolite and is detected in asthma elicited by allergen, viruses, aspirin, there are significant translational implications for asthma. The short-term goals of this K08 award application are to provide training in advanced imaging techniques, advanced genomic techniques, including RNA-Seq, and human translational research. Dr. Bankova's long-term goal is to develop an independent translational research program studying the innate immune control of allergic disease. During the period of support the candidate will complement her laboratory skills with didactic coursework to develop skills in emerging gene sequencing and editing methods, courses in bioinformatics and systems biology, grant writing, leadership, and the responsible conduct of research germane to the application. This will then facilitate her transition to independence during the third and fourth years of the award. Dr. Bankova will work under the mentorship of Nora Barrett, MD and Joshua Boyce, MD, experts in cysLT biology and mechanisms of inflammation. Dr. Bankova has also assembled a team of extraordinary scientists, including Drs. Yoshihide Kanaoka, Carla Kim, Bruce Levy, Howard Katz, and K. Frank Austen, who have committed their time, resources, and expertise to facilitate her career development and research goals. Under their mentorship and guidance, in an ideal scientific environment at the Brigham and Women's Hospital, training in immunology, didactic curriculum, and career development plan will position the candidate to secure independent NIH funding and to establish herself as a physician scientist with a focus on the role of mast cells and cysLTs in instructing epithelial cell activation to guide immune bias at mucosal surfaces.

项目摘要/摘要：该提案详细介绍了为候选人洛拉·班克瓦（Lora Bankova）提供的五年计划，并成为过敏和免疫学领域的独立研究者的专业知识。这研究重点是稳定的白细胞三烯（CYSLT）代谢物的先前未认识的作用 LTE4在控制近端事件的控制中导致2型免疫对室外模具的发展 Aeroallergen，替代品。结合细胞和分子方法，候选者将检验GPR99驱动先天2型免疫力和气道重塑的假设控制IL-25生成的上皮细胞激活。因为LTE4是唯一稳定的Cyslt代谢物，并且在过敏原，病毒，阿司匹林引起的哮喘中检测到，具有显着的翻译意义哮喘。该K08奖励申请的短期目标是提供高级培训成像技术，先进的基因组技术，包括RNA-Seq和人类翻译研究。 Bankova博士的长期目标是制定独立的翻译研究计划研究过敏性疾病的先天免疫控制。在支持期间，候选人将通过教学课程来补充她的实验室技能，以发展新兴基因的技能测序和编辑方法，生物信息学和系统生物学的课程，赠款写作，领导力，以及对应用程序的负责任行为。这将有助于她在奖项的第三年和第四年过渡到独立。 Bankova博士将工作在医学博士Nora Barrett和医学博士Joshua Boyce的指导下，Cyslt Biology和炎症机制。 Bankova博士还召集了一个非凡科学家的团队，包括Drs。 Yoshihide Kanaoka，Carla Kim，Bruce Levy，Howard Katz和K. Frank Austen，谁已经花了时间，资源和专业知识来促进她的职业发展和研究目标。在他们的指导和指导下，在杨百翰的理想科学环境中妇女医院，免疫学培训，教学课程和职业发展计划将定位候选人以确保独立的NIH资金并确立自己的医生科学家的重点是肥大细胞和Cyslt在指导上皮细胞激活中的作用粘膜表面的免疫偏置。